Neuralstem, Inc. (AMEX:CUR), which is planning to raise approximately $18.7 million from the sale of the units, is looking for acquisitions. The copmpany intends to use the net proceeds from this offering for general corporate purposes, including general working capital, the repayment of outstanding loans, capital expenditures, research and development expenditures, clinical trial expenditures, acquisitions of new technologies or businesses and investments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 USD | -2.82% |
|
-3.80% | -51.41% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.41% | 4.03M | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+49.05% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Neuralstem Mulls Acquisitions